• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性扩张型心肌病的频率回顾与荟萃分析。

Review and metaanalysis of the frequency of familial dilated cardiomyopathy.

机构信息

Department of Internal Medicine, Cardiology, Heart Surgery and Immunological Sciences, University Federico II of Naples, Italy.

出版信息

Am J Cardiol. 2011 Oct 15;108(8):1171-6. doi: 10.1016/j.amjcard.2011.06.022. Epub 2011 Jul 26.

DOI:10.1016/j.amjcard.2011.06.022
PMID:21798502
Abstract

Several studies have investigated the frequency of familial dilated cardiomyopathy (FDC). However, no systematic review and meta-analysis on this topic are available. Therefore, using the PubMed, MEDLINE, Cochrane, and the ISI Web of Science databases, relevant reports published through December 2010 were identified. For the summation of prevalence findings, prevalence point estimates and 95% confidence intervals were computed using the logit transformation formula. An aggregate estimate of clinically confirmed FDC of 23% (95% confidence interval 0.17 to 0.31) was found. However, the prevalence rates reported across these studies varied widely, ranging from 2% to 65%, and the analysis showed very high heterogeneity (Q = 295, p <0.001, I(2) = 93%). Meta-regression analysis between logit event rate and year of publication explained 23% of between-study variance (p <0.05). Cumulative meta-analysis confirmed the influence of year of publication on the reported prevalence of FDC among the different studies. However, most of the observed heterogeneity may be explained by the fact that the various studies used different preselected criteria for the diagnosis of FDC. In conclusion, data obtained from trials performed using standardized criteria are needed to better define the true prevalence of FDC.

摘要

已有几项研究调查了家族性扩张型心肌病(FDC)的频率。然而,目前尚无关于该主题的系统评价和荟萃分析。因此,我们使用 PubMed、MEDLINE、Cochrane 和 ISI Web of Science 数据库,检索了截至 2010 年 12 月发表的相关报告。对于患病率发现的汇总,使用对数转换公式计算患病率点估计值和 95%置信区间。发现临床确诊的 FDC 的总体估计值为 23%(95%置信区间为 0.17 至 0.31)。然而,这些研究报告的患病率差异很大,范围从 2%至 65%,分析显示异质性非常高(Q=295,p<0.001,I²=93%)。对数事件率与出版年份之间的元回归分析解释了研究间变异的 23%(p<0.05)。累积荟萃分析证实了出版年份对不同研究中报告的 FDC 患病率的影响。然而,大多数观察到的异质性可能归因于这样一个事实,即各种研究使用不同的预先选择的标准来诊断 FDC。总之,需要使用标准化标准进行的试验获得的数据来更好地定义 FDC 的真实患病率。

相似文献

1
Review and metaanalysis of the frequency of familial dilated cardiomyopathy.家族性扩张型心肌病的频率回顾与荟萃分析。
Am J Cardiol. 2011 Oct 15;108(8):1171-6. doi: 10.1016/j.amjcard.2011.06.022. Epub 2011 Jul 26.
2
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Oxycodone for cancer-related pain.羟考酮治疗癌性疼痛。
Cochrane Database Syst Rev. 2022 Jun 9;6(6):CD003870. doi: 10.1002/14651858.CD003870.pub7.
7
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
8
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
9
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
10
Antioxidants for female subfertility.用于女性生育力低下的抗氧化剂。
Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD007807. doi: 10.1002/14651858.CD007807.pub3.

引用本文的文献

1
Cardiac magnetic resonance markers of pre-clinical hypertrophic and dilated cardiomyopathy in genetic variant carriers.基因变异携带者临床前期肥厚型和扩张型心肌病的心脏磁共振标志物
BMC Med. 2025 Jul 15;23(1):421. doi: 10.1186/s12916-025-04226-4.
2
Perinuclear organelle trauma at the nexus of cardiomyopathy pathogenesis arising from loss of function mutation.由功能丧失突变引起的心肌病发病机制中的核周细胞器损伤。
Nucleus. 2025 Dec;16(1):2449500. doi: 10.1080/19491034.2024.2449500. Epub 2025 Jan 9.
3
Implantable Cardiac Devices in Patients with Brady- and Tachy-Arrhythmias: An Update of the Literature.
缓慢性和快速性心律失常患者的植入式心脏装置:文献综述
Rev Cardiovasc Med. 2024 May 11;25(5):162. doi: 10.31083/j.rcm2505162. eCollection 2024 May.
4
Implementing a clinical scientist-led screening clinic for hypertrophic and dilated cardiomyopathies.设立由临床科学家主导的肥厚型和扩张型心肌病筛查诊所。
Echo Res Pract. 2024 Apr 17;11(1):10. doi: 10.1186/s44156-024-00045-0.
5
Genetic heterogeneity of cardiomyopathy and its correlation with patient care.心肌病的遗传异质性及其与患者治疗的相关性。
BMC Med Genomics. 2023 Oct 30;16(1):270. doi: 10.1186/s12920-023-01639-z.
6
Cardiovascular Magnetic Resonance Imaging in Familial Dilated Cardiomyopathy.家族性扩张型心肌病的心血管磁共振成像。
Medicina (Kaunas). 2023 Feb 23;59(3):439. doi: 10.3390/medicina59030439.
7
Allele-specific expression analysis for complex genetic phenotypes applied to a unique dilated cardiomyopathy cohort.针对复杂遗传表型的等位基因特异性表达分析应用于独特的扩张型心肌病队列。
Sci Rep. 2023 Jan 11;13(1):564. doi: 10.1038/s41598-023-27591-7.
8
Case Report: A novel desmoplakin mutation in a taiwanese woman with familial dilated cardiomyopathy that necessitated heart transplantation.病例报告:一名患有家族性扩张型心肌病且需要心脏移植的台湾女性身上发现一种新的桥粒斑蛋白突变。
Front Genet. 2022 Sep 23;13:954931. doi: 10.3389/fgene.2022.954931. eCollection 2022.
9
Prevalence and Cumulative Risk of Familial Idiopathic Dilated Cardiomyopathy.家族性特发性扩张型心肌病的患病率和累积风险。
JAMA. 2022 Feb 1;327(5):454-463. doi: 10.1001/jama.2021.24674.
10
Dilated cardiomyopathy: a new insight into the rare but common cause of heart failure.扩张型心肌病:对心力衰竭罕见但常见病因的新见解。
Heart Fail Rev. 2022 Mar;27(2):431-454. doi: 10.1007/s10741-021-10125-6. Epub 2021 Jul 10.